跳至主要内容
临床试验/NCT01658618
NCT01658618Unknown不适用

A Non-Interventional Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer

Healthpoint0 个研究点目标入组 440 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
Healthpoint
入组人数
440
主要终点
Primary Objective

研究概览

简要总结

This observations safety study is intended for subject who participated in the 802-247-09-029 study with the investigational product HP802-247 for venous leg ulcers and received at least one application of HP802-247 or Vehicle (an inactive substance). This study is being done for the following purposes:

  1. to identify new adverse events,
  2. to examine ongoing adverse events not resolved in subjects who participated in the 802-247-09-029 trial,
  3. to record wound status, and
  4. to determine if there are differences in Health Related Quality of Life (HRQoL) associated with the treatment assignment from the 802-247-09-029 Trial.

Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provide informed consent document
  • Subject was randomized in 802-247-09-029 and received at least one application of a test article.
  • Subject has ended their participation in 802-247-09-029 by virtue of completing the study, or by dropping out prior to completion.

排除标准

  • Subjects who refuse to provide written informed consent will be excluded from this trial.

结局指标

主要结局

Primary Objective

时间窗: 12 months

The objectives of this study are to identify new adverse events, examine ongoing adverse events not resolved in subjects who participated in the 802-247-09-029 trial, and record wound status.

次要结局

  • Exploratory Objectives(12 Months)

研究者

发起方
Healthpoint
申办方类型
Industry
责任方
Sponsor

相似试验